Susquehanna International Group, LLP Zentalis Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $870 - $1,371	300 Added 1.05%	28,800 $105,000
Q2 2024 Aug 15, 2024	SELL	$4.09 - $16.13 $58,487 - $230,659	-14,300 Reduced 33.41%	28,500 $116,000
Q1 2024 May 07, 2024	SELL	$10.83 - $16.49 $617,310 - $939,929	-57,000 Reduced 57.11%	42,800 $674,000
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $275,520 - $563,640	28,000 Added 39.0%	99,800 $1.51 Million
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $445,601 - $642,183	22,700 Added 46.23%	71,800 $1.44 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $854,831 - $1.48 Million	49,100 New	49,100 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$18.07 - $25.6 $314,418 - $445,440	-17,400 Reduced 44.5%	21,700 $437,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $392,462 - $615,562	19,400 Added 98.48%	39,100 $847,000
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $472,824 - $1.38 Million	-26,400 Reduced 57.27%	19,700 $554,000
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $336,798 - $655,209	8,100 Added 21.32%	46,100 $2.13 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $3.56 Million - $4.51 Million	-53,200 Reduced 58.33%	38,000 $3.19 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $3.49 Million - $5.48 Million	74,600 Added 449.4%	91,200 $6.08 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $621,006 - $1.03 Million	16,600 New	16,600 $883,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $178M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.